Skip to main content

mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance.

Bu C, Zhao L, Wang L, Yu Z, Zhou J
Oncol Res. 2023 Jun 27;31(4):495-503. doi: 10.32604/or.2023.029309. eCollection 2023. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article